Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 3, 2007, Pages 1044-1050

  Meisdalen, Kristin ^a,c   Dajani, Olav F ^a,b   Christoffersen, Thoralf ^a   Sandnes, Dagny ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 9ALPHA DIHYDROXY 11BETA FLUORO 15 (2,3 DIHYDRO 1H INDEN 2 YL) 16,17,18,19,20 PENTANORPROSTADIEN 1 OIC ACID; BUTAPROST; CYCLIC AMP; DNA; EPIDERMAL GROWTH FACTOR; FLUPROSTENOL; GLUCAGON; INOSITOL PHOSPHATE; MISOPROSTOL; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN E1 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN E3 RECEPTOR; PROSTAGLANDIN E4 RECEPTOR; PROSTAGLANDIN F; PROSTAGLANDIN F RECEPTOR; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 34548102696     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.121277     Document Type: Article

References (41)

1. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, et al. (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483:285-293.
2. Andreis PG, Whitfield JF, and Armato U (1981) Stimulation of DNA synthesis and mitosis of hepatocytes in primary cultures of neonatal rat liver by arachidonic acid and prostaglandins. Exp Cell Res 134:265-272.
3. Boie Y, Stocco R, Sawyer N, Slipetz DM, Ungrin MD, Neuschäfer-Rube F, Püschel GP, Metters KM, and Abramovitz M (1997) Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol 340:227-241.
4. Breyer RM, Bagdassarian CK, Myers SA, and Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690.
5. Brønstad GO and Christoffersen T (1981) Inhibitory effect of prostaglandins on the stimulation by glucagon and adrenaline of formation of cyclic AMP in rat hepatocytes. Eur J Biochem 117:369-374.
6. Casado M, Callejas NA, Rodrigo J, Zhao X, Dey SK, Bosca L, and Martin-Sanz P (2001) Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J 15:2016-2018.
7. Chang SH, Ai Y, Breyer RM, Lane TF, and Hla T (2005) The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Cancer Res 65:4496-4499.
8. Christoffersen T, Thoresen GH, Dajani OF, Melien Ø, Guren T, Refsnes M, and Sandnes D (2000) Mechanisms of hepatocyte growth regulation by hormones and growth factors, in The Hepatocyte Review (Berry MN and Edwards AM eds) pp 209-246, Kluwer Academic Publishers, Dordrecht/Boston/London.
9. 2 upregulates EGF-stimulated signalling in mitogenic pathways involving Akt and ERK in hepatocytes. J Cell Physiol, in press.
10. Dajani OF, Sandnes D, Melien Ø, Rezvani F, Nilssen LS, Thoresen GH, and Christoffersen T (1999) Role of diacylglycerol (DAG) in hormonal induction of S phase in hepatocytes: the DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the enhancement of responsiveness to EGF by vasopressin, angiotensin II, and norepinephrine. J Cell Physiol 180:203-214.
11. Fennekohl A, Schieferdecker HL, Jungermann K, and Püschel GP (1999) Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver. J Hepatol 30:38-47.
12. Fennekohl A, Lucas M, and Püschel GP (2000) Induction by interleukin 6 of G(s) -coupled prostaglandin E(2) receptors in rat hepatocytes mediating a prostaglandin E(2)-dependent inhibition of the hepatocyte's acute phase response. Hepatology 31:1128-1134.
13. Fujinaga Y, Morozumi N, Sato K, Tokumitsu Y, Fujinaga K, Kondo Y, Ui M, and Okajima F (1989) A pertussis toxin-sensitive GTP-binding protein plays a role in the G0-G1 transition of rat hepatocytes following establishment in primary culture. FEBS Lett 245:117-121.
14. Fulton AM, Ma X, and Kundu N (2006) Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 66:9794-9797.
15. Garrity MJ, Reed MM, and Brass EP (1989) Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein. J Pharmacol Exp Ther 248:979-983.
16. Griffin BW, Klimko P, Crider JY, and Sharif NA (1999) AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J Pharmacol Exp Ther 290:1278-1284.
17. Hashimoto N, Watanabe T, Ikeda Y, Yamada H, Taniguchi S, Mitsui H, and Kurokawa K (1997) Prostaglandins induce proliferation of rat hepatocytes through a prostaglandin E2 receptor EP3 subtype. Am J Physiol 272:G597-G604.
18. Kataoka K, Takikawa Y, Lin SD, and Suzuki K (2005) Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes. J Gastroenterol 40:610-616.
19. Katoh H, Watabe A, Sugimoto Y, Ichikawa A, and Negishi M (1995) Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells. Biochim Biophys Acta 1244:41-48.
20. Kimura M, Osumi S, and Ogihara M (2001) Prostaglandin E(2) (EP(1)) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of TGF-alpha. Endocrinology 142:4428-4440.
21. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, and Narumiya S (1997) Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122:217-224.
22. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, and Dubinett SM (2005) Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65:6275-6281.
23. Little P, Skouteris GG, Ord MG, and Stocken LA (1988) Serum from partially hepatectomized rats induces primary hepatocytes to enter S phase: a role for prostaglandins? J Cell Sci 91:549-553.
24. Melien Ø, Winsnes R, Refsnes M, Gladhaug IP, and Christoffersen T (1988) Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes. Eur J Biochem 172:293-297.
25. Melien Ø, Sandnes D, Johansen EJ, and Christoffersen T (2000) Effects of pertussis toxin on extracellular signal-regulated kinase activation in hepatocytes by hormones and receptor-independent agents: evidence suggesting a stimulatory role of G(i) proteins at a level distal to receptor coupling. J Cell Physiol 184:27-36.
26. Michalopoulos GK (1990) Liver regeneration: molecular mechanisms of growth control. FASEB J 4:176-187.
27. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, and Narumiya S (1993) Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365:166-170.
28. Narumiya S, Sugimoto Y, and Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
29. Neuschäfer-Rube F, DeVries C, Hanecke K, Jungermann K, and Püschel GP (1994) Molecular cloning and expression of a prostaglandin E2 receptor of the EP3 beta subtype from rat hepatocytes. FEBS Lett 351:119-122.
30. Nilssen LS, Ødegård J, Thoresen GH, Molven A, Sandnes D, and Christoffersen T (2004) G protein-coupled receptor agonist-stimulated expression of ATF3/LRF-1 and c-myc and comitogenic effects in hepatocytes do not require EGF receptor transactivation. J Cell Physiol 201:349-358.
31. Nilssen LS, Dajani O, Christoffersen T, and Sandnes D (2005) Sustained diacylglycerol accumulation resulting from prolonged G protein-coupled receptor agonist-induced phosphoinositide breakdown in hepatocytes. J Cell Biochem 94:389-402.
32. Pérez S, Maldonado EN, Aspichueta P, Ochoa B, and Chico Y (2004) Differential modulation of prostaglandin receptor mRNA abundance by prostaglandins in primary cultured rat hepatocytes. Mol Cell Biochem 266:183-189.
33. Refsnes M, Thoresen GH, Dajani OF, and Christoffersen T (1994) Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2 alpha: additivity with the effect of norepinephrine, and synergism with epidermal growth factor. J Cell Physiol 159:35-40.
34. Refsnes M, Dajani OF, Sandnes D, Thoresen GH, Røttingen JA, Iversen JG, and Christoffersen T (1995) On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C. J Cell Physiol 164:465-473.
35. Rudnick DA, Perlmutter DH, and Muglia LJ (2001) Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 98:8885-8890.
36. Sharif NA, Kelly CR, Crider JY, Williams GW, and Xu SX (2003) Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther 19:501-515.
37. Sheng H, Shao J, Washington MK, and DuBois RN (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:18075-18081.
38. Skouteris GG, Ord MG, and Stocken LA (1988) Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J Cell Physiol 135:516-520.
39. Southall MD and Vasko MR (2001) Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276:16083-16091.
40. 2+-dependent intracellular pathway in NIH-3T3 cells. J Biol Chem 269:17619-17625.
41. 2 stimulates vascular smooth muscle cell proliferation via the EP2 receptor. Mol Cell Endocrinol 203:77-90.